Announcements
Sarah Cannon Research Institute, YCC, and SCH Announce Intent to Collaborate I am pleased to announce that we are finalizing plans to collaborate with the Sarah Cannon Research Institute (SCRI), the nation's premier clinical research institute, to enhance clinical trial opportunities at Yale Cancer Center. As part of the collaboration, SCRI would meet regularly with us to discuss strategic scientific priorities for certain tumor types and to develop clinical research protocols. I look forward to sharing the full details of our agreement later this month.
Peter Marks and Marcella Nunez-Smith Recognized for Outstanding Teaching Dean Alpern recognized two Yale Cancer Center members during the Yale School of Medicine Commencement ceremonies with awards for excellence in teaching. Dr. Peter Marks, Associate Professor of Hematology and Chief Clinical Officer for Smilow Cancer Hospital, was awarded the
Charles W. Bohmfalk Prize for teaching in the basic sciences and Dr. Marcella Nunez-Smith, Assistant Professor of Medicine and a member of the Yale Cancer Center Prevention and Control Research Program, received the Leah M. Lowenstein Award for excellence in the promotion of humane and egalitarian medical education. Please join me in congratulating Peter and Marcella for their outstanding accomplishments. Anne Chiang recruited to Lead Network Development Anne Chiang, MD, PhD will join Yale Cancer Center and Smilow Cancer Hospital on October 1 as an Assistant Professor of Medical Oncology and Chief Medical Officer for the Smilow Cancer Hospital Network. Dr. Chiang's primary responsibility will be to lead our efforts to develop a network of community-based care facilities throughout Connecticut and to oversee those relationships.
Dr. Chiang was previously practicing at Connecticut Hematology & Oncology in New Milford, CT. She received her PhD from Harvard University and her medical degree from Cornell Medical College.
Prior to private practice, Dr. Chiang did her internship and residency at NY Presbyterian Hospital and a Fellowship at Memorial Sloan-Kettering Cancer Center.
Dr. Chiang is currently participating in the ASCO Leadership Development Program.
Please Join us for the Annual ASCO Review Yale Cancer Center members receive complimentary registration for our annual ASCO Review, CME Conference, on Wednesday, June 22 at Yale's West Campus. The agenda includes presentations from Yale Cancer Center faculty on the newest updates from this month's ASCO meeting in Chicago, including a highlight from Julie Sosa's presentation on the FACT Trial, and a keynote address by Dan DiMaio.
Learn More >> Register Now >> Yale Cancer Center Retreats We appreciate the time and effort that so many of our members put into making the annual Yale Cancer Center scientific retreat and the YCC-UCL joint retreat a success last week. A special thank you to Susan Silva and Hilary Prosnitz for all of their hard work planning both events. If you attended one or both of the retreats, please take a few minutes to provide us with some feedback. Take Survey >> |
Development Update UTC Chairman and CEO Louis Chênevert Named Chair of the Yale Cancer Center Advisory Board Yale Cancer Center is pleased to announce the appointment of Louis Chênevert as Chairman of the Center's Advisory Board. Mr. Chênevert is Chairman and Chief Executive Officer of United Technologies Corp. and has been a member of Yale Cancer Center's Advisory Board since 2001.
In addition, he served as co-chairman of the Campaign Committee for Smilow Cancer Hospital at Yale-New Haven from 2007 - 2010.
The Yale Cancer Center Director's Advisory Board is a group of active volunteers who are knowledgeable and informed advocates for the Center. This advocacy includes actively promoting the mission of Yale Cancer Center, as well as participation in fundraising activities intended to provide financial support for Yale Cancer Center. |
Smilow Cancer Hospital Advanced Vascular Imaging Services Available Smilow Cancer Hospital is now offering full service non-invasive vascular ultrasound and physiological testing on the second floor of the hospital in the diagnostic imaging suites. Led by Leslie Scoutt, MD, screening for varicose veins, venous insufficiency, carotid ultrasound, transcranial doppler aortic aneurysms, renal artery stenosis, lower and upper arterial bypass grafts, dialysis access transplant, hepatic/TIPS, portal, mesenteric vascular imaging, lower and upper venous Doppler for DVT, vein mapping, and segmental pressure ABI/PVR is available. To schedule a patient exam, please call (203) 688-2433. |
Notables Ruslan Medzhitov, PhD, a member of the Yale Cancer Center Cancer Immunology Program, is one of three scientists awarded the prestigious Shaw Prize in Life Science and Medicine for 2011. Medzhitov has made groundbreaking contributions to the understanding of innate immunity, which provides immediate defense against infection. Learn More >> Meena Moran, MD, has recently been nominated to join the editorial board of the Journal of Clinical Oncology (JCO). Dr. Moran is an Associate Professor of Therapeutic Radiology and a member of the Yale Cancer Center Radiobiology & Radiotherapy Research Program.
Anthony Koleske, PhD and Titus Boggon, PhD, both members of the Yale Cancer Center Signal Transduction Program, are the recipients of a 2011 Women's Health Research at Yale Pilot Grant, co-funded by Yale Cancer Center. Their research will focus on new drug development to selectively target breast cancer metastasis. Learn More >> Congratulations to the following Yale Cancer Center and Smilow Cancer Hospital clinicians who were selected for inclusion in the 2011 New York Magazine's "Best Doctors" list: Jean Bolognia John Colberg Richard Edelson Sukru Emre Harris Foster Howard Hochster Sivlio Inzucchi John Kveton David Leffell Walter Longo Thomas Lynch Peter Marks Shirley McCarthy Pasquale Patrizio John Persing Richard Peschel Joseph Piepmeier Carrie Redlich Kenneth Roberts Thomas Rutherford Clarence Sasaki J. Grant Thomson Robert Udelsman Jeffrey Weinreb Lynn Wilson |
Funding and Award Opportunities
Department of Defense Lung Cancer Research Program Concept Award Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer
Emphasis is on innovation
Early Investigator Synergistic Idea Award Supports collaborations between two independent investigators early in their careers who address an innovative and high impact lung cancer research question from synergistic and complementary perspectives
This award is designed to promote collaborations between a clinician and laboratory scientist
Investigator Initiated Translational Research Award Supports translational research that will accelerate the movement of promising ideas in lung cancer into clinical applications
Must include preliminary data that is relevant to lung cancer and the proposed project
This award does not support clinical trials, but may support correlative studies that are associated with an existing clinical trial and projects that develop endpoints for clinical trials
Promising Clinician Research Award Supports a research project performed by promising physician-researchers
This award is intended to prepare physicians with clinical duties and/or responsibilities for an independent and active career in lung cancer research Learn More >>
|
SABCS Call for Abstracts
Less than one month remains for submission of abstracts to the world's most renowned and largest breast cancer meeting, the San Antonio Breast Cancer Symposium. This year's symposium will be held December 6 - 10.
Abstracts are due by 11:59 pm CDT US on June 21.Learn More >>
|
NCI Etiologic and Early Marker Studies Program
The NCI has established an Etiologic and Early Marker Studies (EEMS) Program, which includes a biospecimen repository for biospecimens collected from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. The PLCO Biorepository contains approximately 2.7 million biologic specimens, including blood specimens collected from intervention participants during their six trial screening years and buccal cell specimens collected from control participants. These specimens were thus collected before diagnosis of cancer and may be of great value for investigators studying early detection biomarkers. Applications to access specimens are accepted twice per year; the next deadline is July 15. Learn More >>
|
Recent Publications
An integrated approach to segmentation and nonrigid registration for application in image-guided pelvic radiotherapy.
Lu C, Chelikani S, Papademetris X, Knisely JP, Milosevic MF, Chen Z, Jaffray DA, Staib LH, Duncan JS.
Med Image Anal. 2011 May 20.
Read More >>
Ongoing challenges in the endoscopic management of hilar cholangiocarcinoma.
Aslanian HR, Jamidar PA.
Dig Dis Sci. 2011 May;56(5):1255-6.
Read More >>
Developing a Scale to Measure Parental Worry and Their Attitudes Toward Childhood Cancer After Successful Completion of Treatment: A Pilot Study.
Duran B.
J Pediatr Oncol Nurs. 2011 Jun 2.
Read More >>
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody.
Bellone M, Cocco E, Varughese J, Bellone S, Todeschini P, El-Sahwi K, Carrara L, Guzzo F, Schwartz PE, Rutherford TJ, Pecorelli S, Marshall DJ, Santin AD.
Int J Gynecol Cancer. 2011 May 30.
Read More >>
Inhibition of Aurora A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.
Chefetz I, Holmberg JC, Alvero AB, Visintin I, Mor G.
Cell Cycle. 2011 Jul 1;10(13).
Read More >>
Patient Preferences After Endoscopic Ultrasound With Fine Needle Aspiration (EUS-FNA) Diagnosis of Pancreas Cancer: Rapid Communication Valued Over Long-Term Relationships.
Siddiqui UD, Rossi F, Padda MS, Rosenthal LS, Aslanian HR.
Pancreas. 2011 May 19.
Read More >>
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.
Herbst RS, Ansari R, Bustin F, Flynn P, Hart L, Otterson GA, Vlahovic G, Soh CH, O'Connor P, Hainsworth J.
Lancet. 2011 May 28;377(9780):1846-54.
Read More >>
Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique.
Zhang W, Tan S, Paintsil E, Dutschman GE, Gullen EA, Chu E, Cheng YC.
Biochem Pharmacol. 2011 May 18.
Read More >>
Neoadjuvant Chemoradiation for Clinically Advanced Non-Small Cell Lung Cancer: An Analysis of 233 Patients.
Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP.
Ann Thorac Surg. 2011 May 25.
Read More >>
|
| |
|
Countdown to the CCSG Submission 473 days
until our CCSG
grant is due on
September 25, 2012.
|
Join Yale Cancer Center on Facebook
|
Inside Yale Cancer Center
Hope, Not Fear Yale Cancer Center and Smilow Cancer Hospital will hold our annual breast cancer symposium, Hope, Not Fear, on Tuesday, June 21st.Please encourage your patients to attend. Learn More >>
In the News Read recent articles featuring experts from Yale Cancer Center. Learn More >>
Subscribe to Yale Cancer Center Answers on iTunes
Yale Cancer Center's weekly radio program on CT Public Radio is ranked number 2 in the world for cancer programs on iTunes. Subscribe to the show.
Learn More >>
Cancer Bytes
Hosted by Ellen Matloff, listen to the latest interview with Nathan: Advanced Colon Cancer at age 21 - Not your Average College Experience. Learn More >>
Yale Cancer Center Grand Rounds
Video presentations from Yale Cancer Center members are now available online.
Learn More >>
DirectConnect Archives
Learn More >>
|
Events
June 12; 6:00 PM Yale Cancer Center Answers WNPR Thyroid Cancer Julie Ann Sosa, MD Learn More >>
June 14; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Title TBD Joseph Schlessinger, PhD June 15; 12:30 PM Cancer Immunology Seminar SHM B-201 TAMing Mucosal Inflammation Carla Rothlin, PhD Learn More >> (PDF) June 16; 9:00 AM Therapeutic Radiology Grand Rounds SCH LL Medical Error Disclosure Attitudes of Radiation Oncologists Suzanne Evans, MD, MPH Learn More >> June 19; 6:00 PM Yale Cancer Center Answers WNPR Pediatric Bone Marrow Transplantation Deborah Chirnomas, MD, MPH Learn More >> June 21; 8:00 AM Hope, Not Fear Breast Cancer Conference Yale's West Campus Learn More >> (PDF) June 21; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street HPV DNA Methylation-based Secondary Cervical Cancer Screening Janet Brandsma, MD |
New Faculty Recruits (May 2009 - Present)
Anees Chagpar Surgical Oncology Sandy Chang Lab Medicine Anne Chiang Medical Oncology Lieping Chen Immunobiology Deborah Chirnomas Pediatric Oncology Leonard Farber Medical Oncology Mark Faries Surgical Oncology
Valentina Greco Genetics Stephanie Halene Hematology
Roy Herbst Medical Oncology Howard Hochster Medical Oncology Erin Hofstatter Medical Oncology Nina Horowitz Surgical Oncology Michael Hurwitz Medical Oncology Benjamin Judson Otolaryngology Alfred Lee Hematology Arthur Levy Medical Oncology Miguel Materin Ophthalmology Daniel Morgensztern Medical Oncology Don Nguyen Pathology Abhijit Patel Therapeutic Radiology Nikolai Podoltsev Hematology Katie Politi Pathology Tara Sanft Medical Oncology Stacey Stein Medical Oncology Matthew Strout Hematology Narendra Wajapeyee Pathology Qin Yan Pathology |
Submissions
Please submit your recent publication and grant announcements to:
Renee Gaudette
Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
|
|
